NMS feem ntau tau zoo dua hauv 1 txog 2 lub lis piam. Tom qab rov qab los, cov neeg feem coob tuaj yeem pib noj tshuaj tiv thaiv kab mob ntxiv. Koj tus kws kho mob yuav hloov koj mus rau lwm yam tshuaj. NMS tuaj yeem rov qab los tom qab koj kho.
Yuav ua li cas koj thim rov qab neuroleptic malignant syndrome?
Kev kho tshuaj kho mob zoo tshaj plaws tseem tsis tau paub meej. Dantrolene tau siv thaum xav tau los txo cov nqaij ntshiv, thiab tsis ntev los no cov tshuaj dopamine pathway xws li bromocriptine tau pom muaj txiaj ntsig. Amantadine yog lwm txoj kev kho mob vim nws cov tshuaj dopaminergic thiab anticholinergic.
Koj yuav kho tus mob neuroleptic malignant syndrome li cas?
Hauv qhov mob hnyav dua ntawm NMS, empiric pharmacologic therapy feem ntau yog sim. Ob cov tshuaj nquag siv yog bromocriptine mesylate, dopamine agonist, thiab dantrolene sodium, cov leeg nqaij so uas ua haujlwm los ntawm inhibiting calcium tso tawm los ntawm sarcoplasmic reticulum.
Yuav ua li cas yog qhov txaus ntshai tshaj plaws ntawm kev muaj tus mob neuroleptic malignant syndrome?
Neuroleptic malignant syndrome tau tshaj tawm ntau zaus hauv cov neeg mob noj haloperidol thiab chlorpromazine. Lithium ntawm cov tshuaj lom neeg kuj tseem tuaj yeem tshaj tawm ua rau mob neuroleptic malignant syndrome. Cov teeb meem txaus ntshai tshaj plaws rau neuroleptic malignant syndrome cuam tshuam rau lub sijhawm kho mob.
Puas yog neuroleptic malignant syndrome muaj xwm txheej ceev?
INTRODUCTION- Neuroleptic malignant Syndrome (NMS) yog ib qho kev phom sij txog kev ntxhov siab txog kev ntxhov siab cuam tshuam nrognrog kev siv cov tshuaj tiv thaiv kab mob (neuroleptic) thiab tus cwj pwm los ntawm kev kho mob tshwj xeeb ntawm kev puas siab puas ntsws hloov pauv, rigidity, kub taub hau, thiab dysautonomia.
